ESC 365 - Oral paricalcitol therapy reduces arterial stiffness in hypertensive patients with chronic kidney disease and secondary hyperparathyroidism: Data from a 1-year follow-up study

ESC Premium Access

Oral paricalcitol therapy reduces arterial stiffness in hypertensive patients with chronic kidney disease and secondary hyperparathyroidism: Data from a 1-year follow-up study

Session: Best Posters session 4 - Best Posters in drug therapy and blood pressure lowering

Topic: Hypertension, other

Speaker: Doctor K. Dimitriadis (Athens, GR)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Kyriakos Dimitriadis

Hippokration General Hospital, Athens (Greece)

2 presentations

0 follower

4 more presentations in this session

Discussant: Best Posters in drug therapy and blood pressure lowering

ZD100: a novel cyclic GMP activating ANP-based designer peptide in experimental hypertension with structural insights into its unique carboxy-terminus

Speaker: Doctor J. Burnett Jr (Rochester, US)

Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis

Speaker: Professor K. Rahimi (Oxford, GB)

Stress management techniques for the management of idiopathic hypertension

Speaker: Doctor L. Papadaki (Athens, GR)

Access the full session

Best Posters session 4 - Best Posters in drug therapy and blood pressure lowering

Speakers: Doctor K. Dimitriadis, Doctor J. Burnett Jr, Professor K. Rahimi, Doctor L. Papadaki

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources